G107E (p.Gly107Glu) variant of KRT4 (Keratin, type II cytoskeletal 4)

G107E (p.Gly107Glu) in KRT4 (Keratin, type II cytoskeletal 4) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.74 / 1. The record also includes population frequency data and structural context.

G107E (p.Gly107Glu) variant details